Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nuvalent, Inc. - Class A Common Stock (NQ:NUVL)

105.97 +2.97 (+2.89%)
Streaming Delayed Price Updated: 12:15 PM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nuvalent, Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >
News headline image
Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths ↗
Nuvalent and Iteos delivered promising updates in their lung cancer studies. But three patients died in one test. 
Via Investor's Business Daily
Topics Death
News headline image
Crude Oil Surges Over 1%; Instil Bio Shares Plunge ↗
 
Via Benzinga
News headline image
Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio? ↗
 
Via Benzinga
News headline image
NUVL Stock Earnings: Nuvalent Misses EPS for Q2 2024 ↗
NUVL stock results show that Nuvalent missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
NUVL Stock Earnings: Nuvalent Misses EPS for Q1 2024 ↗
NUVL stock results show that Nuvalent missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Recap: Nuvalent Q4 Earnings ↗
 
Via Benzinga
News headline image
Recap: Nuvalent Q3 Earnings ↗
 
Via Benzinga
News headline image
3 Short-Squeeze Stocks Poised for a Jaw-Dropping Rally ↗
Although short-squeeze stocks to buy present great risk, betting against the bears can also yield dramatically robust returns. 
Via InvestorPlace
News headline image
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio? ↗
Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts. 
Via Benzinga
News headline image
7 Biotech Stocks to Get In Now Before Investors Catch On ↗
Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them. 
Via InvestorPlace
News headline image
Why Nuvalent Stock Tanked on Tuesday ↗
The dilution monster stalked the company following the announcement of a new capital-raising effort. 
Via The Motley Fool
News headline image
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet ↗
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance... 
Via Benzinga
News headline image
Where Nuvalent Stands With Analysts ↗
 
Via Benzinga
News headline image
Why Nuvalent Stock Was Soaring Wednesday ↗
The company reported preliminary data on a non-small cell lung cancer therapy. 
Via The Motley Fool
News headline image
Why Nuvalent Stock Skyrocketed 35% This Week ↗
Nuvalent announced favorable preliminary data in a clinical trial for its lung cancer drug. Here's what investors need to know. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold ↗
Stifel initiated coverage on Nuvalent Inc (NASDAQ: NUVL), recognizing that adopting a bullish stance in anticipation of Phase 1 cancer drug data, mainly when derived from heavily pretreated patients,... 
Via Benzinga
News headline image
Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Expert Ratings for Nuvalent ↗
 
Via Benzinga
News headline image
Nuvalent: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023 ↗
 
Via Benzinga
News headline image
Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday ↗
U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
7 A-Rated Biotech Stocks for Your August Buy List ↗
Investing in biotech stocks means accepting a long R&D window, but the rewards when your A-rated biotech stocks come through are huge. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗
 
Via Benzinga
News headline image
$21.8 Million Bet On Nuvalent? 4 Stocks Insiders Are Buying ↗
Although US stocks closed higher on Monday, there were a few notable insider trades. 
Via Benzinga
News headline image
$7.8 Million Bet On Appian? 4 Stocks Insiders Are Buying ↗
Although US stocks closed lower on Thursday, there were a few notable insider trades. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023 ↗
 
Via Benzinga
News headline image
TuSimple, Y-mAbs Therapeutics And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023 ↗
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.